日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Serum TARC dynamics during anti-PD1-based first-line Hodgkin lymphoma treatment: An analysis from the GHSG NIVAHL trial

抗PD-1一线霍奇金淋巴瘤治疗期间血清TARC动态变化:来自GHSG NIVAHL试验的分析

Plattel, Wouter J; Teesink, Sophie; Visser, Lydia; Voltin, Conrad-Amadeus; Kaul, Helen; Schlößer, Hans A; Kroesen, Bart-Jan; Kobe, Carsten; von Tresckow, Bastian; Borchmann, Peter; Diepstra, Arjan; Bröckelmann, Paul J

Serum TARC: a biomarker for early detection or exclusion of relapse in classic Hodgkin lymphoma

血清TARC:经典霍奇金淋巴瘤复发早期检测或排除的生物标志物

Teesink, Sophie A; Visser, Lydia; Nijland, Marcel; Keijzer, Kylie; Niezink, Anne G H; Kroesen, Bart-Jan; van den Berg, Anke; Diepstra, Arjan; Plattel, Wouter J

Trends in allergen-reactive CRTH2+ T cells and TARC associated with successful outcomes in a phase 2 cashew oral immunotherapy study

一项 2 期腰果口服免疫疗法研究中,过敏原反应性 CRTH2+ T 细胞和 TARC 的变化趋势与治疗成功相关

Sindher, Sayantani B; Fernandes, Andrea; Manohar, Monali; Cao, Shu; Gupta, Sheena; Parsons, Ella; Bogetic, Dinara; Kumar, Divya; Rogers, Jessica; Thompson, Julia; Dunham, Diane; Do, Evan; Maysel-Auslender, Sofia; Liu, Taryn Audrey; Martinez, Kristine; Anderson, Brent; Kaushik, Abhinav; Desai, Manisha; Maecker, Holden; Perry, Susan; Wheatley, Lisa M; Nadeau, Kari C; Chinthrajah, R Sharon

Increased Levels of Inflammatory Proteins, Including TARC/CCL17, in Skin of AD Patients During JAK Inhibitor Treatment

在接受JAK抑制剂治疗期间,AD患者皮肤中包括TARC/CCL17在内的炎症蛋白水平升高

Boesjes, Celeste M; van der Gang, Lian F; Bakker, Daphne S; den Hartog Jager, C F; de Graaf, Marlies; de Bruin-Weller, Marjolein S; van Wijk, Femke; Knol, Edward F

Polymorphism's MBOAT7 as Risk and MTARC1 as Protection for Liver Fibrosis in MASLD

多态性MBOAT7与MASLD中肝纤维化的风险相关,而MTARC1则具有保护作用。

Rocha, Sofia; Oliveira, Claudia P; Stefano, José Tadeu; Yokogawa, Roberta P; Gomes-Gouvea, Michele; Zitelli, Patricia Momoyo Youshimura; Silva-Etto, Joyce Matie Kinoshita; Martins, Eduarda Donegá; Pessoa, Mario G; Alcantara, Flavio F; Azevedo, Raymundo S; Rebello Pinho, João Renato

Elevated Serum MCP-2 and TARC Associated With Increased Risk of Death in Guamanian ALS Patients

关岛ALS患者血清MCP-2和TARC水平升高与死亡风险增加相关

Chowdhury, Risana N; Azam, Mus'ab A; Azam, Suhaib A; Lana, Shteynman; Culver, Erin N; Garruto, Ralph M; Wander, Katherine

Dupilumab Achieves Early Disease Control in Bullous Pemphigoid: A Case Series with TARC-based Biomarker Evaluation

度普利尤单抗在类天疱疮早期控制病情:基于TARC生物标志物的病例系列评估

Takamura, Saori; Fukuda, Tomoo

An In-Depth Statistical Analysis of the TARC Parameter to Evaluate the Real Impact of Random Phases in MIMO Antennas

对TARC参数进行深入统计分析,以评估MIMO天线中随机相位的实际影响

Perez-Miguel, Angel; Jardon-Aguilar, Hildeberto; Tirado-Mendez, Jose Alfredo; Gomez-Villanueva, Ricardo; Flores-Leal, Ruben; Fritz-Andrade, Erik

YOLO-TARC: YOLOv10 with Token Attention and Residual Convolution for Small Void Detection in Root Canal X-Ray Images

YOLO-TARC:基于 YOLOv10、Token Attention 和残差卷积的根管 X 光图像小空隙检测算法

Pan, Yin; Zhang, Zhenpeng; Zhang, Xueyang; Zeng, Zhi; Tian, Yibin

Effect of dupilumab for the therapy of atopic dermatitis and the effect on serum TARC, HBD2 and SEA-IgE levels and peripheral blood T helper cell subtypes

度普利尤单抗治疗特应性皮炎的效果及其对血清TARC、HBD2和SEA-IgE水平以及外周血T辅助细胞亚型的影响

Xin Tian ,Junlong Li ,Haiyan Xu ,Jingyao Liang ,Yan Yang ,Aili Gao ,Xiaolan Zhao ,Lei Shao ,Jing Zhang ,Qianru Ye ,Rujun Xue ,Qiongxiao Huang ,Yihui Yu ,Manqi Xia ,Xiaodong Li ,Jiang Wu ,Ruihua Fang ,Jianqin Wang ,Yumei Liu